Ford JG, Koh MJ, Lenart AW, et al. Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas. Blood Adv. 2025;9(16):4286-4305.

Read full text

Fields of Study & Subjects

Cutaneous lymphoproliferative disorders research Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research

Publication details

Journal / source
Blood Advances
Volume
10
Issue
3
Pages
660–660
Publication date
29 January 2026
Language
EN